15 October 2021
The BioMed21 Collaboration recently contributed to several sessions within WC11—the 11th World Congress on Alternatives and Animal Use in the Life Sciences. This triennial event was postponed in summer 2020 and took place virtually between August 23 – September 2 this year. With more than 100 sessions, 30 exhibitors and sponsors, and 500 e-posters, it was as vibrant and busy as a real-life event!
Click on the links below to access our presentations associated with our ongoing projects and efforts around the globe:
- Brinda Poojary
The Process for the Deletion of ATT, TABST and LABST in India
- Laura Viviani
Remove ATT, TABST & LABST: How far away are we to global harmonization for those safety tests?
- Lindsay Marshall
A 21st-century roadmap for biomedical research and drug discovery: Recommendations
Overview of new approaches in biomedical research – the BioMed21 Collaboration
Available and emerging non-animal models for human respiratory tract diseases
- Marcia Triunfol
Animal data reliance bias in peer review: a barrier to scientific progress
- Surat Parvatam
Asia is a ripe place for alternatives to animal testing
- Borami Seo
Promoting alternatives to animal testing methods through stakeholder collaboration
What do you think? Please share your thoughts and comments below.